Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells

Biochemical and Biophysical Research Communications

Volumn 361, Issue 2, 2007, Pages 362-366

  Chen, Xiao Ping ^a   Liu, Shou ^a   Tang, Wen Xin ^a   Chen, Zheng Wang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Apoptosis; Breast cancer; Nucleus; p53; Thioredoxin 1

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53; THIOREDOXIN; THIOREDOXIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RNA, MESSENGER; THIOREDOXIN; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 34547532196     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.033     Document Type: Article

References (21)

1. Toshio T., Hiroko K., and Hiroko F. Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem. Biophys. Res. Commun. 307 (2003) 765-770
2. Arnold N.B., Ketterer K., Kleeff J., Friess H., Büchler M.W., and Korc M. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer. Cancer Res. 64 (2004) 3599-3606
3. Ma X., Karra S., Lindner D.J., Hu J., Reddy S.P., Kimchi A., Yodoi J., and Kalvakolanu D.V. Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination. Oncogene 20 (2001) 3703-3715
4. Dashnamoorthy R., Harish M., and Kumuda C.D. Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. J. Biol. Chem. 280 (2005) 40084-40096
5. Grogan T., Fenoglio P.C., Zaheb R., Bellamy W., Vela E., Richter L., and Powis G. Overexpression of thioredoxin, a putative oncogene, in gastric carcinoma with associated change in proliferation and apoptosis. Human Path. 31 (2000) 475-481
6. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. 94 (1997) 3633-3638
7. Walter H.W., and Dean P.J. Oxidation of nuclear thioredoxin during oxidative stress. FEBS Lett. 543 (2003) 144-147
8. Makino Y., Yoshikawa N., Okamoto K., Hirota K., Yodoi J., Makino I., and Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem. 274 (1999) 3182-3188
9. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus: a two-step mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274 (1999) 27891-27897
10. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
11. Young M.G., Thomas R.Z., Jennifer M.J., Li G., Jason M.H., and Dean P.J. Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells. Free Radic. Biol. Med. 42 (2007) 363-370
12. Freeman R.E., and Neuzil J. Role of thioredoxin-1 in apoptosis induction by alpha-tocopheryl succinate and TNF-related apoptosis-inducing ligand in mesothelioma cells. FEBS Lett. 580 (2006) 2671-2676
13. Nishinaka Y., Nishiyama A., Masutani H., Oka S.I., Ahsan K.M., Nakayama Y., Ishii Y., Nakamura H., Maeda M., and Yodoi J. Loss of thioredoxin-binding protein-2/Vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res. 64 (2004) 1287-1292
14. Kim S.J., Miyoshi Y., Taguchi T., Tamaki Y., Nakamura H., Yodoi J., Kato K., and Noguchi S. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res. 11 (2005) 8425-8430
15. Yamada M., Tomida A., Yoshikawa H., Taketani Y., and Tsuruo T. Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human avarian and colon cancer cell lines. Cancer Chemother. Pharmacol 40 (1997) 31-37
16. Wei S.J., Botero A., Hirota K., Bradbury C.M., Markovina S., Laszlo A., Spitz D.R., Goswami P.C., Yodoi J., and Gius D. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res. 60 (2000) 6688-6695
17. Yamada M., Tomida A., Yoshikawa H., Taketani Y., and Tsuruo T. Increased expression of thioredoxin/adult T-cell leukemiaderived factor in cisplatin-resistant human cancer cell lines. Clin. Cancer Res. 2 (1996) 427-432
18. Powis G., Mustacich D., and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29 (2000) 312-322
19. Ueno M., Matsutani Y., Nakamura H., Masutani H., Yagi M., Yamashiro H., Kato H., Inamoto T., Yamauchi A., Takahashi R., Yamaoka Y., and Yodoi J. Possible association of thioredoxin and p53 in breast cancer. Immunol. Lett. 75 (2000) 15-20
20. Liang Z.Q., Li Y.L., Zhao X.L., Han R., Wang X.X., Wang Y., Chase T.N., Bennett M.C., and Qin Z.H. NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. Brain Res. 1145 (2007) 190-203
21. Azuma M., Tamatani T., Ashida Y., Takashima R., Harada K., and Sato M. Cisplatin induces apoptosis in oral squamous carcinoma cells by the mitochondria-mediated but not the NF-κB-suppressed pathway. Oral Oncol. 39 (2003) 282-289